Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(3)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 33

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07545395Phase 3Recruiting
Safety of KN057 Prophylaxis in Patients With Haemophilia A or B
Hemophilia A or B
PrincipalinvestigatorStart date: 2026-03-13
NCT06569108Phase 3Active Not Recruiting
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
PrincipalinvestigatorStart date: 2024-04-01
NCT06312475Phase 3Active Not Recruiting
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors
Hemophilia A With InhibitorHemophilia B With Inhibitor
PrincipalinvestigatorStart date: 2024-01-09

Research Network

Collaboration Network

39 collaborators·81 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Yanping Song, Doctor

Xi'an Central Hospital

Similar
3 trials

Shared therapeutic areas:

Hemophilia A or BHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Hu Zhou, Doctor

Henan Cancer Hospital

Similar
3 trials

Shared therapeutic areas:

Hemophilia A or BHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Renchi Yang, Doctor

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

Similar
4 trials

Shared therapeutic areas:

Hemophilia A or BHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Changcheng Zheng, Doctor

The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)

Similar
4 trials

Shared therapeutic areas:

Hemophilia A or BHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Sujun Gao, Doctor

Bethune First Hospital of Jilin University

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Ziqiang Yu, Doctor

The First Affiliated Hospital of Soochow University

Moderately Similar
3 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Runhui Wu, Doctor

Beijing Children's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Wei Yang, Doctor

Shengjing Hospital of China University

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Yaming Xi, Doctor

LanZhou University

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Jingyu Yan, Doctor

North China University of Science and Technology

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07545395Phase 3PrincipalInvestigator

Safety of KN057 Prophylaxis in Patients With Haemophilia A or B

Hemophilia A or B
Recruiting
NCT06569108Phase 3PrincipalInvestigator

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Active Not Recruiting
NCT06312475Phase 3PrincipalInvestigator

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

Hemophilia A With InhibitorHemophilia B With Inhibitor
Active Not Recruiting

All 3 trials loaded